Article Commentary: Fundamentals of Liver Surgery for the Practicing General Surgeon

Couinaud C. , Delmas A. , Patel J. Le Foie; etudes anatomiques et chirurgicales. Paris, Masson. 1957.

Terminology Committee of the International Hepato-Pancreato-Biliary Association. IHPBA Brisbane 2000 Terminology of Liver Anatomy and Resections. HPB 2000; 2(3): 333–39.

Bismuth H. Surgical anatomy and anatomical surgery of the liver. World J Surg 1982; 6: 3–9.

Bismuth H. , Houssin D. , Castaing D. Major and minor segmentectomies ‘Réglées’ in liver surgery. World J Surg 1982; 6: 10–24.

Liau K.H. , Blumgart L.H. , DeMatteo R.P. Segment-oriented approach to liver resection. Surg Clin North Am 2004; 84: 543–61.

Michels N.A. Newer anatomy of the liver and its variant blood supply and collateral circulation. Am J Surg 1962; 112: 337–47.

Hiatt J.R. , Gabbay J. , Busuttil R.W. Surgical anatomy of the hepatic arteries in 1000 cases. Ann Surg 1994; 220: 50–2.

Gruttadauria S. , Scotti F.C. , Doria C. The hepatic artery in liver transplantation and surgery: vascular anomalies in 701 cases. Clin Transplant 2001; 15: 359–63.

Pugh R.N.H. , Murray-Lyon I.M. , Dawson J.L. Transection of the oesophagus for bleeding oesophageal varices. Br J Surg 1973; 60: 646–9.

Child C.G. , Turncotte J.G. Surgery and portal hypertension. In: Child C.G. , ed. The Liver and Portal Hypertension: Major Problems in Clinical Surgery. Philadelphia: W.B. Saunders Company; 1964: 50.

Trey C. , Burns D.G. , Saunders S.J. Treatment of hepatic coma by exchange blood transfusion. N Engl J Med 1966; 274: 473–81.

Llovet J.M. , Bru C. , Bruix J. Prognosis of hepatocellular carcinoma: the BCLC staging classification. Semin Liver Dis 1999; 19: 329–38.

Kamath P.S. , Wiesner R.H. , Malinchoc M. A model to predict survival in patients with end-stage liver disease. Hepatology 2001; 33: 464–70.

United Network for Organ Sharing (UNOS). The model for end-stage liver disease (MELD) and pediatric end-stage liver disease (PELD) numeric scales currently used for liver allocation. 2008. Available at: www.unos.org/resources/MeldPeldCalculator.asp. Accessed November 15, 2009.

Farnsworth N. , Fagan S.P. , Berger D.H. Child-Turcotte-Pugh versus MELD score as a predictor of outcome after elective and emergent surgery in cirrhotic patients. Am J Surg 2004; 188: 580–3.

Northrup P.G. , Wanamaker R.C. , Lee V.A. Model for end-stage liver disease (MELD) predicts nontransplant surgical mortality in patients with cirrhosis. Ann Surg 2005; 242: 244–51.

Teh S.H. , Nagorney D.M. , Stevens S.R. Clinical—liver, pancreas, and biliary tract. Risk factors for mortality in patients with cirrhosis. Gastroenterology 2007; 132: 1261–9.

Madoff D.C. , Abdalla E.K. , Vauthey J.N. Portal vein embolization in preparation for major hepatic resection: evolution of a new standard of care. J Vasc Interv Radiol 2005; 16: 779–90.

Cowles R.A. , Mulholland M.W. Solitary hepatic cysts. J Am Coll Surg 2000; 191: 311–21.

Martin I.J. , McKinley A.J. , Currie E.J. Tailoring the management of nonparasitic liver cysts. Ann Surg 1998; 228: 167–72.

Montorsi M. , Torzilli G. , Fumagalli U. Percutaneous alcohol sclerotherapy of simple hepatic cysts. Results from a multicentre survey in Italy. HPB Surg 1994; 8: 89–94.

Hansman M.F. , Ryan J.A. Jr. , Holmes J.H. IV Management and long-term follow-up of hepatic cysts. Am J Surg 2001; 181: 404–10.

Gigot J.F. , Legrand M. , Hubens G. Laparoscopic treatment of nonparasitic liver cysts: adequate selection of patients and surgical technique. World J Surg 1996; 20: 556–61.

Koffron A. , Rao S. , Ferrario M. Intrahepatic biliary cystadenoma: role of cyst fluid analysis and surgical management in the laparoscopic era. Surgery 2004; 136: 926–86.

Thomas K.T. , Welch D. , Trueblood A. Effective treatment of biliary cystadenoma. Ann Surg 2005; 241: 769–75.

Vogt D.P. , Henderson J.M. , Chmielewski E. Cystadenoma and cystadenocarcinoma of the liver: a single center experience. J Am Coll Surg 2005; 200: 727–33.

Gibbs J.F. , Litwin A.M. , Kahlenberg M.S. Contemporary management of benign liver tumors. Surg Clin N Am 2004; 84: 463–80.

Yoon S.S. , Charny C.K. , Fong Y. Diagnosis, management, and outcomes of 115 patients with hepatic hemangioma. J Am Coll Surg 2003; 197: 392–402.

Herman P. , Costa M.L.V. , Machado M.A.C. Management of hepatic hemangiomas: a 14-year experience. J Gastrointest Surg 2005; 9: 853–9.

Kammula U.S. , Buell J.F. , Labow D.M. Surgical management of benign tumors of the liver. Int J Gastrointest Cancer 2001; 30: 141–6.

Wanless I.R. Benign liver tumors. Clin Liver Dis 2002; 6: 513–26.

Choi B.Y. , Nguyen M.H. The diagnosis and management of benign hepatic tumors. J Clin Gastroenterol 2005; 39: 401–12.

Terkivatan T. , de Wilt J.H.W. , de Man R.A. Indications and long-term outcome of treatment for benign hepatic tumors. Arch Surg 2001; 136: 1033–8.

Mathieu D. , Kobeiter H. , Maison P. Oral contraceptive use and focal nodular hyperplasia of the liver. Gastroenterology 2000; 118: 560–4.

Nuguyen B.N. , Fléjou J.F. , Terris B. Focal nodular hyperplasia of the liver: a comprehensive pathologic study of 30 lesions and recognition of new histologic forms. Am J Surg Pathol 1999; 23: 1441–54.

Cherqui D. , Rahmouni A. , Charlotte F. Management of focal nodular hyperplasia and hepatocellular adenoma in young women: a series of 41 patients with clinical, radiological, and pathological correlations. Hepatology 1995; 22: 1674–81.

Fabre A. , Audet P. , Vilgrain V. Histologic scoring of liver biopsy in focal nodular hyperplasia with atypical presentation. Hepatology 1995; 35: 414–20.

Brancatelli G. , Federle M.P. , Grazioli L. Focal nodular hyperplasia: CT findings with emphasis on multiphasic helical CT in 78 patients. Radiology 2001; 219: 61–8.

Colli A. , Fraquelli M. , Massironi S. Elective surgery for benign liver tumors. The Cochrane Library 2009, Issue 4. 2009. The Cochrane Collaboration. John Wiley & Sons, Ltd. Data Base of System Reviews, Issue 3. Available at: www.thecochranelibrary.com. Accessed November 15, 2009.

Grazioli L. , Federle M.P. , Brancatelli G. Hepatic adenomas: imaging and pathologic findings. Radiographics 2001; 21: 877–92.

Deneve J.L. , Pawlik T.M. , Cunningham S. Liver cell adenoma: a multicenter analysis of risk factors for rupture and malignancy. Ann Surg Oncol 2009; 16: 640–8.

Lovet J.M. , Schwartz M. , Mazzaferro V. Resection and liver transplantation for hepatocellular carcinoma. Semin Liver Dis 2005; 25: 181–200.

Fong Y. , Sun R.L. , Jarnagin W. , Blumgart L.H. An analysis of 412 cases of hepatocellular carcinoma at a Western center. Ann Surg 1999; 229: 790–800.

Esnaola N.F. , Mirza N. , Lauwers G.Y. Comparison of clinicopathologic characteristics and outcomes after resection in patients with hepatocellular carcinoma treated in the United States, France, and Japan. Ann Surg 2003; 238: 711–9.

Bruix J. , Sherman M. Management of hepatocellular carcinoma. Hepatology 2005; 42: 1208–36.

Llovet J.M. , Fuster J. , Bruix J. Intention-to-treat analysis of surgical treatment for early hepatocellular carcinoma: resection versus transplantation. Hepatology 1999; 30: 1434–40.

Bilimoria M.M. , Lauwers G.Y. , Doherty D.A. Underlying liver disease, not tumor factors, predicts long-term survival after resection of hepatocellular carcinoma. Arch Surg 2001; 136: 528–35.

Livraghi T. , Solbiati L. , Meloni M.F. Treatment of focal liver tumors with percutaneous radio-frequency ablation: complications encountered in a multicenter study. Radiology 2003; 226: 441–51.

Vivarelli M. , Guglielmi A. , Ruzzenente A. Surgical resection versus percutaneous radiofrequency ablation in the treatment of hepatocellular carcinoma on cirrhotic liver. Ann Surg 2004; 240: 102–7.

Curley S.A. , Izzo F. , Ellis L.M. Radiofrequency ablation of hepatocellular cancer in 110 patients with cirrhosis. Ann Surg 2000; 232: 381–91.

Llovet J.M. , Real M.I. , Montaña X. Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomized controlled trial. Lancet 2002; 359: 1734–9.

Lo C.M. , Ngan H. , Tso W.K. Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma. Hepatology 2002; 35: 1164–71.

Llovet J.M. , Ricci S. , Mazzaferro V. Sorafenib in advanced hepatocellular carcinoma. N Engl J Med 2008; 359: 378–90.

Pawlik T.M. , Choti M.A. Surgical therapy for colorectal metastases to the liver. J Gastrointest Surg 2007; 11: 1057–77.

Ferrero A. , Vigano L. , Polastri R. Postoperative liver dysfunction and future liver remnant: where is the limit? World J Surg 2007; 31: 1643–51.

Shah S.A. , Haddad R. , Al-Sukhni W. Surgical resection of hepatic and pulmonary metastases from colorectal carcinoma. J Am Coll Surg 2006; 202: 468–75.

Adam R. , Delvart V. , Pascal G. Rescue surgery for un-resectable colorectal liver metastases downstaged by chemotherapy. A model to predict long-term survival. Ann Surg 2004; 240: 644–57.

Jaeck D. , Oussoultzoglou E. , Rosso E. A two-stage hepatectomy procedure combined with portal vein embolization to achieve curative resection for initially unresectable multiple and bilobar colorectal liver metastases. Ann Surg 2004; 240: 1037–49.

Abdalla E.K. , Vauthey J.N. , Ellis L.M. Recurrence and outcomes following hepatic resection, radiofrequency ablation, and combined resection/ablation for colorectal liver metastases. Ann Surg 2004; 239: 818–27.

Amersi F.F. , McElrath-Garza A. , Ahmad A. Long-term survival after radiofrequency ablation of complex unresectable liver tumors. Arch Surg 2006; 141: 581–8.

Kronawitter U. , Kemeny N.E. , Heelan R. Evaluation of chest computed tomography in the staging of patients with potentially resectable liver metastases from colorectal carcinoma. Cancer 1999; 86: 229–35.

Yang Y. , Fleshman J.W. , Strasberg S.M. Detection and management of extrahepatic colorectal cancer in patients with resectable liver metastases. J Gastrointest Surg 2007; 11: 929–44.